Cargando…

Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction

BACKGROUND: Diagnostic value of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) in the assessment of myocardial viable segments is well known; hence, it can identify patients with left ventricular (LV) systolic dysfunction who may benefit from revascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangamuthu, Brithika Yoganayaki, Elangovan, Indirani, Asra, Patel, Simon, Shelley, Sathyamoorthy, Immaneni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348504/
https://www.ncbi.nlm.nih.gov/pubmed/37456177
http://dx.doi.org/10.4103/ijnm.ijnm_74_22
_version_ 1785073678958985216
author Thangamuthu, Brithika Yoganayaki
Elangovan, Indirani
Asra, Patel
Simon, Shelley
Sathyamoorthy, Immaneni
author_facet Thangamuthu, Brithika Yoganayaki
Elangovan, Indirani
Asra, Patel
Simon, Shelley
Sathyamoorthy, Immaneni
author_sort Thangamuthu, Brithika Yoganayaki
collection PubMed
description BACKGROUND: Diagnostic value of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) in the assessment of myocardial viable segments is well known; hence, it can identify patients with left ventricular (LV) systolic dysfunction who may benefit from revascularization. The presence of significant myocardial viable segments before revascularization will offer better prognosis with reduced mortality and morbidity. However, the usage of F18-FDG PET/CT myocardial viability study in the presurgical risk stratification is limited. OBJECTIVE: The objective of the study is to predict perioperative mortality with hibernating viable myocardial (HVM) segments established by F18-FDG PET/CT in comparison with EuroSCORE II in patients with LV dysfunction undergoing coronary artery bypass grafting surgery. MATERIALS AND METHODS: A prospective, observational study included 75 patients of chronic ischemic coronary artery disease with ejection fraction ≤40%. Tc-99m sesta-methoxyisobutylisonitrile myocardial perfusion single photon emission CT/CT and myocardial viability with F18-FDG PET/CT at rest were performed. Mortality risk stratification was done according to the EuroSCORE II. Patients were followed for post-coronary artery bypass graft surgery (CABG) 30-day mortality. Mortality observed by HVM segment groups were compared with EuroSCORE II predicted mortality. RESULTS: Receiver operating curve for 30-day mortality prediction with HVM segments and EuroSCORE II was constructed. It showed that a cutoff of <4 HVM segments (area under the curve [AUC] = 0.7) had a sensitivity of 85%, whereas EuroSCORE II (AUC = 0.4) had only 28.6% sensitivity. EuroSCORE II underestimated perioperative risk in patients with <4 viable segments, that is 5 times higher risk was observed in patients with <4 viable segments. CONCLUSIONS: HVM segments established by F18-FDG PET/CT had independently predicted mortality postoperatively. Hence, including F18-FDG PET/CT for viability assessment along with EuroSCORE II in preoperative risk assessment for revascularization by CABG in patients with LV dysfunction provided better risk stratification.
format Online
Article
Text
id pubmed-10348504
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-103485042023-07-15 Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction Thangamuthu, Brithika Yoganayaki Elangovan, Indirani Asra, Patel Simon, Shelley Sathyamoorthy, Immaneni Indian J Nucl Med Original Article BACKGROUND: Diagnostic value of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT) in the assessment of myocardial viable segments is well known; hence, it can identify patients with left ventricular (LV) systolic dysfunction who may benefit from revascularization. The presence of significant myocardial viable segments before revascularization will offer better prognosis with reduced mortality and morbidity. However, the usage of F18-FDG PET/CT myocardial viability study in the presurgical risk stratification is limited. OBJECTIVE: The objective of the study is to predict perioperative mortality with hibernating viable myocardial (HVM) segments established by F18-FDG PET/CT in comparison with EuroSCORE II in patients with LV dysfunction undergoing coronary artery bypass grafting surgery. MATERIALS AND METHODS: A prospective, observational study included 75 patients of chronic ischemic coronary artery disease with ejection fraction ≤40%. Tc-99m sesta-methoxyisobutylisonitrile myocardial perfusion single photon emission CT/CT and myocardial viability with F18-FDG PET/CT at rest were performed. Mortality risk stratification was done according to the EuroSCORE II. Patients were followed for post-coronary artery bypass graft surgery (CABG) 30-day mortality. Mortality observed by HVM segment groups were compared with EuroSCORE II predicted mortality. RESULTS: Receiver operating curve for 30-day mortality prediction with HVM segments and EuroSCORE II was constructed. It showed that a cutoff of <4 HVM segments (area under the curve [AUC] = 0.7) had a sensitivity of 85%, whereas EuroSCORE II (AUC = 0.4) had only 28.6% sensitivity. EuroSCORE II underestimated perioperative risk in patients with <4 viable segments, that is 5 times higher risk was observed in patients with <4 viable segments. CONCLUSIONS: HVM segments established by F18-FDG PET/CT had independently predicted mortality postoperatively. Hence, including F18-FDG PET/CT for viability assessment along with EuroSCORE II in preoperative risk assessment for revascularization by CABG in patients with LV dysfunction provided better risk stratification. Wolters Kluwer - Medknow 2023 2023-06-08 /pmc/articles/PMC10348504/ /pubmed/37456177 http://dx.doi.org/10.4103/ijnm.ijnm_74_22 Text en Copyright: © 2023 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Thangamuthu, Brithika Yoganayaki
Elangovan, Indirani
Asra, Patel
Simon, Shelley
Sathyamoorthy, Immaneni
Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
title Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
title_full Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
title_fullStr Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
title_full_unstemmed Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
title_short Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Cardiac Viability Risk Stratification in Comparison with EuroSCORE II for Revascularization in Patients with Left Ventricular Dysfunction
title_sort fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography cardiac viability risk stratification in comparison with euroscore ii for revascularization in patients with left ventricular dysfunction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348504/
https://www.ncbi.nlm.nih.gov/pubmed/37456177
http://dx.doi.org/10.4103/ijnm.ijnm_74_22
work_keys_str_mv AT thangamuthubrithikayoganayaki fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction
AT elangovanindirani fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction
AT asrapatel fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction
AT simonshelley fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction
AT sathyamoorthyimmaneni fluorine18fluorodeoxyglucosepositronemissiontomographycomputedtomographycardiacviabilityriskstratificationincomparisonwitheuroscoreiiforrevascularizationinpatientswithleftventriculardysfunction